Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STMP
151
DELISTED
Stamps.com, Inc.
STMP
| $64.4M | 0.14% |
587,324
-73,297
| -11% | -$6.71M |
|
|
IDTI
152
DELISTED
Integrated Device Technology I
IDTI
| $64.3M | 0.14% |
2,441,653
-196,800
| -7% | -$5.04M |
|
|
ISBC
153
DELISTED
Investors Bancorp, Inc.
ISBC
| $64.1M | 0.14% |
5,151,987
+796,500
| +18% | +$10M |
|
154
Boston Scientific
BSX
$74.2B
| $64M | 0.14% |
+3,471,705
| New | +$62.2M |
|
155
SLB Ltd
SLB
$79.7B
| $63.8M | 0.14% |
914,593
+837,500
| +1,086% | +$62.7M |
|
156
Molina Healthcare
MOH
$10.2B
| $63.1M | 0.14% |
1,048,578
-35,900
| -3% | -$2.26M |
|
|
ARRS
157
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $62.4M | 0.14% |
2,042,720
| – | – |
|
|
VG
158
DELISTED
Vonage Holdings Corporation
VG
| $62.2M | 0.14% |
10,836,926
+51,100
| +0.5% | +$317K |
|
159
DuPont de Nemours
DD
$19.5B
| $62.1M | 0.14% |
476,385
+96,233
| +25% | +$12.4M |
|
160
Pinnacle West Capital
PNW
$12.1B
| $62M | 0.14% |
961,700
+197,100
| +26% | +$12.5M |
|
|
NUAN
161
DELISTED
Nuance Communications, Inc.
NUAN
| $62M | 0.14% |
3,600,892
+2,804,227
| +352% | +$45.5M |
|
162
DTE Energy
DTE
$28.6B
| $61.8M | 0.13% |
905,690
-42,849
| -5% | -$2.95M |
|
163
Factset
FDS
$10.1B
| $61.7M | 0.13% |
379,350
+100,550
| +36% | +$16.9M |
|
164
Arch Capital
ACGL
$33.5B
| $61.4M | 0.13% |
2,641,800
+198,300
| +8% | +$4.87M |
|
165
Lam Research
LRCX
$390B
| $60.8M | 0.13% |
7,651,560
-593,000
| -7% | -$4.46M |
|
166
Kinross Gold
KGC
$32.3B
| $60.1M | 0.13% |
33,042,099
+3,710,400
| +13% | +$7.33M |
|
|
MGLN
167
DELISTED
Magellan Health Services, Inc.
MGLN
| $60.1M | 0.13% |
974,799
+40,500
| +4% | +$2.17M |
|
168
Papa John's
PZZA
$801M
| $60M | 0.13% |
1,073,400
-56,600
| -5% | -$3.5M |
|
169
CorVel
CRVL
$3.09B
| $60M | 0.13% |
4,095,300
+147,000
| +4% | +$1.81M |
|
170
Intuitive Surgical
ISRG
$142B
| $59.6M | 0.13% |
982,530
-840,834
| -46% | -$47.2M |
|
|
ELNK
171
DELISTED
EarthLink Holdings Corp.
ELNK
| $59.5M | 0.13% |
8,014,439
+620,000
| +8% | +$5.21M |
|
172
Mid-America Apartment Communities
MAA
$15.3B
| $59M | 0.13% |
649,362
+46,100
| +8% | +$4.01M |
|
|
NTRI
173
DELISTED
NutriSystem, Inc.
NTRI
| $58.9M | 0.13% |
2,721,000
+455,289
| +20% | +$10.7M |
|
|
MXIM
174
DELISTED
Maxim Integrated Products
MXIM
| $58.8M | 0.13% |
1,548,100
-365,202
| -19% | -$14M |
|
175
Visa
V
$677B
| $58.8M | 0.13% |
757,700
-1,355,000
| -64% | -$105M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.